<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">28781798</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">2049-9450</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>7</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Molecular and clinical oncology</Title>
          <ISOAbbreviation>Mol Clin Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.</ArticleTitle>
        <Pagination>
          <StartPage>259</StartPage>
          <EndPage>262</EndPage>
          <MedlinePgn>259-262</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3892/mco.2017.1311</ELocationID>
        <Abstract>
          <AbstractText>Paraneoplastic limbic encephalitis (PLE), a paraneoplastic neurological syndrome (PNS), is a rare nervous system disorder that results from the indirect effects of tumors and is commonly associated with small-cell lung cancer (SCLC). Previous studies have reported that magnetic resonance imaging (MRI) may be useful for diagnosing LE. Temporal lobe abnormalities are observed using T2-weighted and fluid-attenuated inversion recovery sequences; however, such abnormalities are detected in only 60% of patients with PLE. The present study describes a case of PLE associated with SCLC, in which LE was observed using MRI 26 days after the first convulsive seizure. Although the serum and cerebrospinal fluid analyses for onconeural antibodies were negative, the findings of this case indicate that PLE should be considered in the differential diagnosis, and that repeated brain MRI may be more helpful for diagnosis, as the brain MRI findings may be normal during the early stages of PLE.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tsunoda</LastName>
            <ForeName>Yoshiya</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kiwamoto</LastName>
            <ForeName>Takumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Homma</LastName>
            <ForeName>Shinsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yabuuchi</LastName>
            <ForeName>Yuuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kitazawa</LastName>
            <ForeName>Haruna</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shiozawa</LastName>
            <ForeName>Toshihiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakazawa</LastName>
            <ForeName>Kensuke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hosaka</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishii</LastName>
            <ForeName>Kazuhiro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishii</LastName>
            <ForeName>Akiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamaoka</LastName>
            <ForeName>Akira</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hizawa</LastName>
            <ForeName>Nobuyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>06</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Clin Oncol</MedlineTA>
        <NlmUniqueID>101613422</NlmUniqueID>
        <ISSNLinking>2049-9450</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">onconeural antibody</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic limbic encephalitis</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic neurological syndromes</Keyword>
        <Keyword MajorTopicYN="N">small-cell lung cancer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28781798</ArticleId>
        <ArticleId IdType="pmc">PMC5532705</ArticleId>
        <ArticleId IdType="doi">10.3892/mco.2017.1311</ArticleId>
        <ArticleId IdType="pii">MCO-0-0-1311</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Höftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 2015;27:489–495. doi: 10.1097/CCO.0000000000000222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCO.0000000000000222</ArticleId>
            <ArticleId IdType="pmc">PMC4640358</ArticleId>
            <ArticleId IdType="pubmed">26335665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481–1494. doi: 10.1093/brain/123.7.1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/123.7.1481</ArticleId>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. PNS Euronetwork: Paraneoplastic neurologic syndrome in the PNS Euronetwork database: A European study from 20 centers. Arch Neurol. 2010;67:330–335. doi: 10.1001/archneurol.2009.341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2009.341</ArticleId>
            <ArticleId IdType="pubmed">20212230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gozzard P, Maddison P. Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol. 2010;10:260–270. doi: 10.1136/jnnp.2010.224105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2010.224105</ArticleId>
            <ArticleId IdType="pubmed">20858627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benatar M, Blaes F, Johnston I, Wilson K, Vincent A, Beeson D, Lang B. Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol. 2001;113:153–162. doi: 10.1016/S0165-5728(00)00431-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-5728(00)00431-8</ArticleId>
            <ArticleId IdType="pubmed">11137587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, et al.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120:1279–1300. doi: 10.1093/brain/120.8.1279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/120.8.1279</ArticleId>
            <ArticleId IdType="pubmed">9278623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenlee JE. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1090. doi: 10.1136/jnnp.2004.038489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2004.038489</ArticleId>
            <ArticleId IdType="pmc">PMC1739162</ArticleId>
            <ArticleId IdType="pubmed">15258205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, Lang B, Maddison P. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study. Neurology. 2015;85:235–239. doi: 10.1212/WNL.0000000000001721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001721</ArticleId>
            <ArticleId IdType="pmc">PMC4516293</ArticleId>
            <ArticleId IdType="pubmed">26109714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380–386. doi: 10.1007/s00234-006-0069-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00234-006-0069-0</ArticleId>
            <ArticleId IdType="pubmed">16586118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, Wu S. Paraneoplastic epilepsy. Epilepsy Behav. 2016;61:51–58. doi: 10.1016/j.yebeh.2016.04.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2016.04.046</ArticleId>
            <ArticleId IdType="pubmed">27304613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764–1777. doi: 10.1093/brain/awh526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awh526</ArticleId>
            <ArticleId IdType="pmc">PMC1939694</ArticleId>
            <ArticleId IdType="pubmed">15888538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheid R, Lincke T, Voltz R, von Cramon DY, Sabri O. Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol. 2004;61:1785–1789. doi: 10.1001/archneur.61.11.1785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.61.11.1785</ArticleId>
            <ArticleId IdType="pubmed">15534190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327–340. doi: 10.1016/S1474-4422(08)70060-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(08)70060-7</ArticleId>
            <ArticleId IdType="pmc">PMC2367117</ArticleId>
            <ArticleId IdType="pubmed">18339348</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">28781798</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">2049-9450</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>7</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Molecular and clinical oncology</Title>
          <ISOAbbreviation>Mol Clin Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.</ArticleTitle>
        <Pagination>
          <StartPage>259</StartPage>
          <EndPage>262</EndPage>
          <MedlinePgn>259-262</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3892/mco.2017.1311</ELocationID>
        <Abstract>
          <AbstractText>Paraneoplastic limbic encephalitis (PLE), a paraneoplastic neurological syndrome (PNS), is a rare nervous system disorder that results from the indirect effects of tumors and is commonly associated with small-cell lung cancer (SCLC). Previous studies have reported that magnetic resonance imaging (MRI) may be useful for diagnosing LE. Temporal lobe abnormalities are observed using T2-weighted and fluid-attenuated inversion recovery sequences; however, such abnormalities are detected in only 60% of patients with PLE. The present study describes a case of PLE associated with SCLC, in which LE was observed using MRI 26 days after the first convulsive seizure. Although the serum and cerebrospinal fluid analyses for onconeural antibodies were negative, the findings of this case indicate that PLE should be considered in the differential diagnosis, and that repeated brain MRI may be more helpful for diagnosis, as the brain MRI findings may be normal during the early stages of PLE.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tsunoda</LastName>
            <ForeName>Yoshiya</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kiwamoto</LastName>
            <ForeName>Takumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Homma</LastName>
            <ForeName>Shinsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yabuuchi</LastName>
            <ForeName>Yuuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kitazawa</LastName>
            <ForeName>Haruna</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shiozawa</LastName>
            <ForeName>Toshihiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakazawa</LastName>
            <ForeName>Kensuke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hosaka</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishii</LastName>
            <ForeName>Kazuhiro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishii</LastName>
            <ForeName>Akiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamaoka</LastName>
            <ForeName>Akira</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hizawa</LastName>
            <ForeName>Nobuyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>06</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Clin Oncol</MedlineTA>
        <NlmUniqueID>101613422</NlmUniqueID>
        <ISSNLinking>2049-9450</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">onconeural antibody</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic limbic encephalitis</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic neurological syndromes</Keyword>
        <Keyword MajorTopicYN="N">small-cell lung cancer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28781798</ArticleId>
        <ArticleId IdType="pmc">PMC5532705</ArticleId>
        <ArticleId IdType="doi">10.3892/mco.2017.1311</ArticleId>
        <ArticleId IdType="pii">MCO-0-0-1311</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Höftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 2015;27:489–495. doi: 10.1097/CCO.0000000000000222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCO.0000000000000222</ArticleId>
            <ArticleId IdType="pmc">PMC4640358</ArticleId>
            <ArticleId IdType="pubmed">26335665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481–1494. doi: 10.1093/brain/123.7.1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/123.7.1481</ArticleId>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. PNS Euronetwork: Paraneoplastic neurologic syndrome in the PNS Euronetwork database: A European study from 20 centers. Arch Neurol. 2010;67:330–335. doi: 10.1001/archneurol.2009.341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2009.341</ArticleId>
            <ArticleId IdType="pubmed">20212230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gozzard P, Maddison P. Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol. 2010;10:260–270. doi: 10.1136/jnnp.2010.224105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2010.224105</ArticleId>
            <ArticleId IdType="pubmed">20858627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benatar M, Blaes F, Johnston I, Wilson K, Vincent A, Beeson D, Lang B. Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol. 2001;113:153–162. doi: 10.1016/S0165-5728(00)00431-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-5728(00)00431-8</ArticleId>
            <ArticleId IdType="pubmed">11137587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, et al.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120:1279–1300. doi: 10.1093/brain/120.8.1279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/120.8.1279</ArticleId>
            <ArticleId IdType="pubmed">9278623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenlee JE. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1090. doi: 10.1136/jnnp.2004.038489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2004.038489</ArticleId>
            <ArticleId IdType="pmc">PMC1739162</ArticleId>
            <ArticleId IdType="pubmed">15258205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, Lang B, Maddison P. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study. Neurology. 2015;85:235–239. doi: 10.1212/WNL.0000000000001721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001721</ArticleId>
            <ArticleId IdType="pmc">PMC4516293</ArticleId>
            <ArticleId IdType="pubmed">26109714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380–386. doi: 10.1007/s00234-006-0069-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00234-006-0069-0</ArticleId>
            <ArticleId IdType="pubmed">16586118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, Wu S. Paraneoplastic epilepsy. Epilepsy Behav. 2016;61:51–58. doi: 10.1016/j.yebeh.2016.04.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2016.04.046</ArticleId>
            <ArticleId IdType="pubmed">27304613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764–1777. doi: 10.1093/brain/awh526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awh526</ArticleId>
            <ArticleId IdType="pmc">PMC1939694</ArticleId>
            <ArticleId IdType="pubmed">15888538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheid R, Lincke T, Voltz R, von Cramon DY, Sabri O. Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol. 2004;61:1785–1789. doi: 10.1001/archneur.61.11.1785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.61.11.1785</ArticleId>
            <ArticleId IdType="pubmed">15534190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327–340. doi: 10.1016/S1474-4422(08)70060-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(08)70060-7</ArticleId>
            <ArticleId IdType="pmc">PMC2367117</ArticleId>
            <ArticleId IdType="pubmed">18339348</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
